Background: A variety of oral proprietary Chinese medicines (OPCMs) have clinical efficacy in the adjunctive treatment of stable chronic obstructive pulmonary disease (COPD). However, the OPCM with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results